More recent studies also suggest a novel role for BD-1047 in attenuating
ethanol-induced
neurotoxicityin vitro, and additional research is being conducted on this compound as a possible pharmacotherapy for alcohol use disorder (AUD) [3]
References
^Skuza G, Rogóz Z (2006). "Effect of BD 1047, a sigma1 receptor antagonist, in the animal models predictive of antipsychotic activity". Pharmacological Reports. 58 (5): 626–35.
PMID17085854.